Current Clinical Islet Transplant Trials
At the Diabetes Research Institute, our clinical trials offer participants the opportunity to play an active role in their own healthcare. Patients involved in diabetes clinical trials can also access potential new treatments before they are widely available. These studies provide important information to advance medical care and are crucial to finding a definitive cure for diabetes.
After a promising new treatment is developed in our laboratory and its safety and effectiveness is carefully tested in the pre-clinical setting, clinical investigators obtain Institutional Review Board (IRB) approval to conduct diabetes clinical trials in patients. Participants receive high-quality care and related study medications throughout the trial at no cost.
We are actively involved in screening individuals for:
Islet Transplant Clinical Trials: Though progress has been substantial, islet transplantation remains an experimental procedure. Our islet transplant studies will continue to focus on improving the safety and long-term function and success of cell transplants.
Participating in a clinical trial for diabetes or any other disease is an important personal decision. To learn more about what’s involved, the National Institutes of Health answers Frequently Asked Questions about clinical trials on its web site. In addition, it is often helpful to talk to a physician, family members, or friends about deciding to join a trial.